Wastewater Surveillance Companies

The wastewater surveillance market is expected to grow from USD 0.88 billion in 2025 to USD 1.22 billion by 2030, at a CAGR of 6.7% during this period.

The global wastewater surveillance market is experiencing rapid growth driven by increasing demand for early detection of public health threats, stricter regulations, and expanding use of environmental monitoring for disease prevention. Demand is rising as governments, health agencies, and research institutions become more aware of wastewater data's role in tracking infectious diseases, antimicrobial resistance (AMR), and chemical contaminants. Surveillance systems are becoming more widespread as advanced analytical technologies, automated sampling systems, and skilled laboratory networks continue to develop and become more accessible.

The range of testing capabilities has grown tremendously, driving the industry toward faster, more sensitive, and more affordable solutions. This includes progress in molecular diagnostics, next-generation sequencing (NGS), biosensors, multiplex PCR assays, and AI-powered data analytics for trend forecasting. The availability of portable, field-ready testing kits and cloud-based reporting platforms has further improved the speed and dependability of results.

To know about the assumptions considered for the study download the pdf brochure

Market leaders succeed through strong laboratory networks, specialized product lines, and strategic partnerships with public health agencies. They invest heavily in R&D to enhance pathogen detection panels, automation, and data integration tools, ensuring better accuracy and faster turnaround times. Companies are also branching into new areas like industrial wastewater compliance, illicit drug monitoring, and environmental impact assessments.

The main players in the wastewater surveillance market include IDEXX Laboratories (US), Bio-Rad Laboratories (US), Eurofins Scientific (Luxembourg), Hach (US), Thermo Fisher Scientific (US), 3M (US), ABB (Switzerland), and Biobot Analytics (US). Competitive strategies from 2021 to 2025 aim to expand laboratory capacities, develop advanced detection platforms, and strengthen global presence through partnerships and government collaboration contracts.

Primary growth strategies include launching new products, forming collaborations, acquiring companies, and expanding services. Over the past three years, companies have increased their efforts in providing integrated sampling-to-analysis solutions, addressing emerging health security needs, and positioning themselves as vital partners in global disease surveillance networks.

IDEXX Laboratories (US) is a leading global provider of water and wastewater testing solutions, widely recognized for its expertise in microbiological testing methods. The company offers a broad portfolio of advanced diagnostic kits, instruments, and reagents for detecting pathogens and contaminants in wastewater, including SARS-CoV-2 and other emerging public health threats. IDEXX invests heavily in R&D to improve detection sensitivity, streamline workflows, and enhance automation in sample processing. With a strong global distribution network, brand recognition, and comprehensive training programs for laboratories and public health agencies, IDEXX is a trusted partner in wastewater surveillance programs worldwide. Its ongoing innovation and commitment to public health enable it to maintain a competitive advantage in this rapidly expanding market.

Thermo Fisher Scientific (US) is a global leader in scientific solutions and a key provider of instruments, reagents, and molecular diagnostic technologies for wastewater surveillance. Its platforms for quantitative PCR, digital PCR, and next-generation sequencing are widely used to detect pathogens, monitor antimicrobial resistance, and track emerging variants in wastewater. Thermo Fisher’s integrated approach — from sample collection and concentration to analysis and cloud-based data interpretation — ensures high accuracy and efficiency. The company’s extensive R&D capabilities, strong customer support, and worldwide presence reinforce its leadership position, enabling public health agencies and research institutions to respond rapidly to evolving threats.

Hach (US), a Danaher company, is a major player in analytical instrumentation for water and wastewater testing. Known for its advanced samplers, sensors, and laboratory instruments, Hach supports both routine monitoring and targeted surveillance programs. The company’s solutions enable precise measurement of microbial, chemical, and physical parameters in wastewater, providing essential data for environmental compliance and public health protection. Hach’s strong product reliability, field service network, and ongoing product innovation ensure its position as a preferred choice for utilities, municipalities, and research organizations engaged in wastewater surveillance.

Market Ranking:

The wastewater surveillance market is somewhat concentrated: a small group of large instrument and reagent makers—led by Thermo Fisher Scientific, IDEXX Laboratories, and Hach (Danaher)—make up a significant part of product revenue across instrumentation, sample prep, and molecular diagnostics because they provide end-to-end platforms used by labs and utilities worldwide. Thermo Fisher and other major life-science suppliers dominate in qPCR/dPCR, NGS, and extraction reagents, while specialized water-testing companies like IDEXX and Hach lead in field samplers, sensors, and validated assay kits. These companies stay in front through extensive R&D, broad product ranges, and global distribution networks. At the same time, the market’s services and testing segments are dominated by large laboratory networks and CRO-style testing groups (e.g., Eurofins, SGS, Biobot Analytics) that purchase instruments from the manufacturers mentioned above and provide sampling-to-report services for public health and utilities. These service providers have expanded rapidly during and after the COVID-19 surveillance expansion, increasing demand for integrated solutions. The remaining market is fragmented, consisting of regional instrument manufacturers, niche reagent suppliers, startups focused on biosensor and onsite detection, and a broad base of local laboratories. While some smaller companies provide innovative, lower-cost, or highly specialized solutions, they generally have limited global reach and must compete based on price, niche performance, or service bundles. As surveillance programs develop, many of these smaller players are either partnering with larger manufacturers, pursuing white-label agreements, or focusing on specific regions and applications (such as AMR monitoring, industrial effluent, and illicit-drug surveillance) to stay competitive and viable.

Related Reports:

Wastewater Surveillance Market by Product (Instruments & Equipment (Samplers, Ultracentrifuge, qPCR, Portable), Assays & Kits, Consumables), Application (Pathogen Detection, AMR Tracking), End User (Public Health, Govt, Hospitals) - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com